ImmuPharma PLC (LON:IMM)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.00 and traded as low as $10.06. ImmuPharma shares last traded at $10.22, with a volume of 451,887 shares.
The stock has a market capitalization of $17.29 million and a PE ratio of -1.99. The business has a fifty day moving average of GBX 12.41. The company has a current ratio of 5.94, a quick ratio of 5.78 and a debt-to-equity ratio of 1.59.
ImmuPharma Company Profile (LON:IMM)
ImmuPharma plc, a pharmaceutical company, develops drug candidates based on peptide therapeutics to treat serious medical conditions. The company's lead product candidate is the Lupuzor, which has completed Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also: What are the FAANG Stocks?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.